NeuroVive Pharmaceutical AB Operative Marge
Was ist das Operative Marge von NeuroVive Pharmaceutical AB?
Operative Marge von NeuroVive Pharmaceutical AB ist -81,248.88%
Was ist die Definition von Operative Marge?
Die operative Marge ist das Verhältnis von Betriebseinkommen zu Nettomsatz und in Prozent dargestellt.
Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.
Operative Marge von Unternehmen in Miscellaneous Sektor auf LSE im Vergleich zu NeuroVive Pharmaceutical AB
Was macht NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Unternehmen mit operative marge ähnlich NeuroVive Pharmaceutical AB
- Shyam Telecom hat Operative Marge von -87,410.21%
- eSense-Lab Ltd hat Operative Marge von -86,333.34%
- Xantippe Resources hat Operative Marge von -85,927.01%
- AXIM Biotechnologies hat Operative Marge von -84,786.21%
- Manhattan hat Operative Marge von -84,131.37%
- Accelerate Resources hat Operative Marge von -81,435.33%
- NeuroVive Pharmaceutical AB hat Operative Marge von -81,248.88%
- Revolution Medicines Inc hat Operative Marge von -80,961.32%
- Southern Gold hat Operative Marge von -79,145.54%
- Seneca Biopharma Inc hat Operative Marge von -78,961.14%
- Eidos Therapeutics Inc hat Operative Marge von -78,625.20%
- AB Active ETFs Inc hat Operative Marge von -77,807.79%
- Icon hat Operative Marge von -77,251.34%